Gallstone disease is one of the most common and costly of all digestive diseases. It is estimated that 10-20% of all US adults have gallstones. Each year, 500,000 people develop symptoms or complications necessitating cholecystectomy.
Discover Enteric Dialysis®, a novel uremic toxin reduction technology leveraging the gut-kidney connection; the transformation from concept into reality, by Dr. Ranganathan and his research team at Kibow Biotech Inc., using clinical findings of pro/prebiotics to modulate the gut microbiome to improve clinical outcomes in CKD patients worldwide.
After regularly being asked how to best implement lifestyle programs, our team has launched a new offering and crafted complementary content that covers all the critical aspects needed to launch an effective program.
This webinar discusses the roles and interactions of all of these genes (genomics), their products (transcriptomics) and the metabolites produced (metabolomics).
Liposomes in the Treatment of Neurological Trauma and Degeneration
On-demand Webinar Bovine colostrum is critical to healing leaky gut syndrome (intestinal permeability) and essential to preventing autoimmune and chro [...]